MARKET NEWS

The Development of Biological Drugs and Biotechnology Will Be Driving Factors of Global Protein Sequencer Market

Protein is indispensable to living systems and is the main carrier of biological functions. They can be used as chemical catalysts, structural components and mediators of physiological processes. Research techniques that accurately identify and quantify proteins can greatly promote the understanding of biology of people. For many diseases that cannot be explained at the genetic level, protein can give people the answers people want. Even if some diseases can be explained at the genetic level, they may have to come back to protein during treatment; for this reason, proteomics has come into being. Scientists predict that with the completion of human genome sequencing, the focus of future life science research may shift from genomics to proteomics.

Protein sequencing is a popular de novo sequencing method for the determination and analysis of the amino acid sequence from the mass spectrum. The process enables researchers obtain information about protein conformation. Protein sequencing has established itself as high throughput proteomic technique and have several applications. One of the prominent applications is in target-based drug discovery. A Protein Sequencer is the machinery for the sequencing process. A range of various computational methods and experimental methods, notably Edman degradation and Mass Spectrometry, is used for protein sequencing. Edman degradation is a sensitive, and simple way to infer the location of phosphoamino acids in an isolated phosphopeptide. Mass spectrometry is one of the most important analytical techniques in the field of protein research and biological macromolecule research. Due to the increasing requirements for protein identification, quantification and analysis, it is hoped that the sensitivity of the detection technology will also be higher and higher, and at the same time more complex samples can be analyzed and processed. Protein sequencer can be applied in biotherapeutics and genetic engineering, and these two application fields respectively covered a market share of 29.59% and 79.41% in 2019. 

The Current Situation of Global Protein Sequencer Industry Market

America was the largest revenue market with a market share of 38.58% in 2015 and 35.73% in 2020 with a decrease of 2.85%. Europe ranked the second market with the market share of 31.50% in 2019. Protein Sequencer companies are mainly from Asia; the industry concentrate rate is very high.

Get the complete sample, please click: https://www.globalmarketmonitor.com/reports/762686-protein-sequencer-market-report.html

Proteomics is the core content of life science research in the postgenomic era. If you want to understand proteins in depth and further understand the molecular mechanisms of life activities and diseases, you must first have the support of appropriate protein sequencing technology. Because of this, protein sequencing is of great significance for marker discovery, disease diagnosis, drug development, and individualized treatment, and has broad application prospects. The direct uses of protein sequencing include: finding probes for DNA sequence analysis; identifying the purity of proteins and peptides; studying the relationship between protein structure and function and the homology of protein structure; determining protein biologically active sites, enzymes Binding to the substrate and catalytic sites; determine the start and end sites of the nucleic acid code and the protein sequence; scientifically explain protein crystal structure, branch points of protein molecules, pathogenesis of molecular genetic diseases, molecular immunity Mechanism etc. Therefore, the need for protein sequencing and the continuous development of related sequencing technologies have become one of the important driving forces of the Protein Sequencer Market.

Global Protein Sequencer Industry Market Development Trend Forecast

At present, in the pharmaceutical field, biological drugs are getting more and more attention. Biopharmaceuticals are protein drugs and antibody drugs developed by biotechnology such as DNA recombination, cell fusion, and cell culture. Almost all protein synthesis starts at the N-terminus, and its sequence composition has an important influence on the overall biological function of the protein. Therefore, protein sequence analysis is very critical for the effect of biological drugs. Increasing focus on target-based drug development activities by biotechnology and pharmaceutical companies in various developing and developed regions is a key factor driving the market. The latest developments in de novor and analytical methods, as well as the application of neural networks, have opened up new avenues for the market. The technological advancement of mass spectrometers is a good example. Increasing the funding of proteomics research in many developing countries and proteomics is a key factor driving market growth. Therefore, as the demand for protein biomarkers in the drug development process continues to grow, the continuous investment in research organizations will further promote the rapid expansion of the protein sequencer market. It is predicted that the value of Protein Sequencer markets can be 51.54 M USD by 2025. The CAGR of Protein Sequencer is 1.42% from 2019 to 2025.

Among all regions, North America has great potential in the Protein Sequencer market. The huge scale of regional revenue is driven by the emerging R&D expenditures of well-known pharmaceutical and biotech companies. In addition, some public and private organizations have invested a lot of money in proteomics research. More and more people are starting to pay attention to structure-based drug design and the emergence of technologically advanced analytical methods for protein sequencing, which are driving demand in the region. In the next few years, the Protein Sequencer market in the Asia-Pacific region will occupy an important share. China is expected to witness the fastest growth rate in the target market during the forecast period. Government initiatives and investments in life sciences research in countries such as Japan and India are expected to increase, thereby boosting development in their regions.

Protein de novor is a field that spans proteomics and bioinformatics, and requires high equipment, personnel and analysis software. Therefore, the factors that affect the accuracy of protein de novor mainly include equipment, personnel and related analysis software. At present, mainstream sequencing services basically require the use of high-resolution mass spectrometers. The instrument itself is relatively expensive and the maintenance cost is high, which will bring corresponding economic pressure on buyers. In recent years, the field of proteomics has developed rapidly in protein production, crystal growth and structure determination technology. In addition, since the use of sequencing technology and instruments involves complex operations, professionals are required to complete the entire process and the lack of well-trained researchers and laboratory professionals is restricting the growth of the Protein Sequencer market.

Get the complete sample, please click: https://www.globalmarketmonitor.com/reports/762686-protein-sequencer-market-report.html